## Does the UK's QTAP Cohort 3 Signal Real Industrial Quantum Traction?

Eleven organisations — including NatWest, the Rail Safety and Standards Board (RSSB), and Health Innovation North West Coast — have joined the third cohort of Digital Catapult's Quantum Technology Access Programme (QTAP), the programme announced on 16 July 2026. For the first time in the programme's history, financial services and banking operations are explicitly in scope, with NatWest targeting fraud detection across large transaction networks. All cohort work will run on hardware physically deployed at the National Quantum Computing Centre (NQCC), specifically ORCA Computing's PT-2 quantum computer, and the programme is scheduled to run until February 2027. The hardware choice is notable: ORCA's PT-2 is a [photonic qubit](https://quantumintel.tech/glossary/photonic-qubit) system, a modality that operates at room temperature and is therefore easier to deploy in a national centre environment than superconducting alternatives requiring dilution refrigerators. Whether the PT-2's current capabilities are sufficient to demonstrate genuine [quantum advantage](https://quantumintel.tech/glossary/quantum-advantage) over classical baselines in these use cases is the core question the cohort's results — due by February 2027 — will need to answer.

---

## What Is QTAP and Who Are the Cohort 3 Participants?

QTAP is Digital Catapult's structured pathway programme designed to take UK-based enterprises from conceptual interest in quantum computing to hands-on experimentation. It is delivered in collaboration with the NQCC's SparQ initiative. Now in its third year, the programme has previously hosted organisations including Vodafone, Airbus, Rolls-Royce, the Port of Dover, and the UK Atomic Energy Authority — a roster that signals serious industrial engagement rather than superficial technology tourism.

Cohort 3's 11 organisations span five sectors named in the source material: finance, healthcare, defence, logistics, and transport. Named participants include:

- **NatWest** — fraud detection and illicit activity mapping across large transaction networks
- **CTA Fintech Solutions** — cross-system optimisation of legacy-to-cloud transaction flows
- **Rail Safety and Standards Board (RSSB)** — transport and infrastructure use cases
- **Health Innovation North West Coast** — diagnostic modelling, treatment pathways, and outcome forecasting for thrombotic thrombocytopenic purpura (TTP), a rare blood disorder

The remaining seven organisations were not individually named in the source material.

The two technical streams the cohort will work within are combinatorial optimisation (logistics, resource allocation, scheduling) and [hybrid quantum-classical](https://quantumintel.tech/glossary/hybrid-quantum-classical) machine learning for data analysis and pattern discovery. These are precisely the application categories where near-term [NISQ](https://quantumintel.tech/glossary/nisq)-era hardware has the most credible short-term case, even without fault tolerance.

---

## The Hardware Question: ORCA Computing's PT-2

The programme's technical anchor is ORCA Computing's PT-2, deployed at the NQCC. ORCA is a UK-based photonic quantum computing company, and the PT-2 is a commercially available system. The source material does not specify the PT-2's qubit count, gate fidelity, or coherence characteristics, so this article will not supply those figures.

What matters analytically is the deployment model: the hardware is physically on-site at the NQCC, not accessed via a cloud API. This matters for the UK's sovereign capability argument. Paul Ceely, Director of Technology Strategy at Digital Catapult, was explicit about this framing in the programme announcement: "I'm excited to see the novel solutions trialed and validated by our new cohort on a real quantum computer deployed at NQCC, which will translate deep tech into a commercial reality."

Dr Simon Plant, Deputy Director for Innovation at the NQCC, added: "Through SparQ, we're helping organisations move towards practical exploration of quantum computing. This cohort demonstrates growing confidence in quantum computing across UK industry."

Neither quote offers performance benchmarks. The language is deliberately directional rather than metric-driven, which is appropriate for a structured exploration programme but should temper expectations about near-term commercial deployment at scale.

---

## Financial Services: The Most Consequential First

The entry of NatWest into QTAP is the single most commercially significant development in Cohort 3. Fraud detection in large transaction networks is a computationally intensive graph problem — identifying anomalous subgraph patterns across millions of nodes is a class of challenge where quantum-enhanced graph algorithms have theoretical merit, even if practical quantum advantage at production scale remains unproven today.

CTA Fintech Solutions' focus on legacy-to-cloud transaction flow optimisation is a combinatorial scheduling problem, a category more immediately tractable on current [NISQ](https://quantumintel.tech/glossary/nisq) hardware using variational approaches such as [QAOA](https://quantumintel.tech/glossary/qaoa). The programme source describes this as optimising for "cost efficiency and resilience in highly regulated environments" — language that maps directly to the kind of constrained optimisation problems that quantum annealing and gate-based variational methods have been tested against by other financial institutions.

The fact that financial services are entering QTAP for the first time in Cohort 3 aligns with a broader pattern visible across the UK and European quantum ecosystem: banks and insurers are moving from watching the space to running structured pilots, even while acknowledging that fault-tolerant hardware capable of definitively outperforming classical solvers at production scale is not yet available.

---

## The Healthcare Use Case: TTP and Quantum Modelling

The TTP diagnostic modelling use case deserves specific attention. Thrombotic thrombocytopenic purpura is a rare, acute, life-threatening blood disorder. Health Innovation North West Coast, part of the UK's Health Innovation Network, will use quantum computing to explore improvements in diagnostic modelling, treatment pathways, and outcome forecasting for TTP patients.

This is a genuinely novel application for a structured quantum access programme. Medical pathway optimisation is a combinatorial problem (scheduling, resource allocation, treatment sequencing) with a clear real-world outcome metric. The involvement of ORCA Computing as technical partner here, providing direct access to the PT-2, gives the use case a concrete hardware substrate. Whether the PT-2's current capabilities can produce clinically meaningful modelling improvements over existing classical solvers will be the real test — and the results, expected by February 2027, should produce publishable evidence one way or the other.

---

## Industry Trajectory: What QTAP Cohort 3 Actually Tells Us

Three data points from this programme are worth tracking against the broader UK quantum strategy:

1. **Sector breadth is widening.** Cohort 1 and 2 alumni include aerospace (Airbus, Rolls-Royce), telecoms (Vodafone), and critical national infrastructure (UK Atomic Energy Authority, Port of Dover). Cohort 3 adds banking, NHS-adjacent healthcare, and rail safety — sectors with stringent regulatory environments and long procurement cycles. Their willingness to commit engineering time to QTAP is a leading indicator of enterprise quantum budgets, not a lagging one.

2. **The sovereign hardware argument is being stress-tested.** All Cohort 3 work runs on an ORCA PT-2 at the NQCC. The UK government has invested significantly in the NQCC as a national asset. Using it as the delivery platform for an industrial access programme is a reasonable way to justify that investment, but the results need to be technically rigorous. Programmes that produce qualitative case studies rather than quantitative benchmarks against classical baselines risk becoming soft marketing for the UK quantum brand rather than evidence of technical progress.

3. **The timeline pressure is real.** February 2027 is seven months away. For financial fraud detection, medical pathway modelling, and rail infrastructure optimisation, producing compelling results within that window will require either selecting problems that are already tractable on near-term photonic hardware, or accepting that the primary output will be characterisation of what is *not* yet possible — which is itself valuable evidence for the industry.

The programme's structure is sound. Digital Catapult and the NQCC are credible institutions. The cohort selection is commercially serious. What Cohort 3 cannot yet claim is demonstrated performance advantage — that benchmark sits seven months in the future, with ORCA's PT-2 doing the work.

---

## Key Takeaways

- Digital Catapult's QTAP Cohort 3 comprises **11 organisations**, including NatWest, RSSB, and Health Innovation North West Coast.
- **Financial services enters the programme for the first time**, with NatWest focusing on fraud detection and CTA Fintech Solutions on legacy-to-cloud transaction optimisation.
- All work runs on **ORCA Computing's PT-2** photonic quantum computer, physically deployed at the NQCC — not via cloud access.
- The two technical streams are **combinatorial optimisation** and **quantum machine learning**.
- A novel healthcare use case targets improved outcomes for **TTP**, a rare blood disorder.
- The programme runs **until February 2027**, when cohort results are expected.
- Previous alumni include Vodafone, Airbus, Rolls-Royce, the Port of Dover, and the UK Atomic Energy Authority.

---

## Frequently Asked Questions

**What is the Digital Catapult Quantum Technology Access Programme (QTAP)?**
QTAP is a UK programme run by Digital Catapult in collaboration with the National Quantum Computing Centre's SparQ initiative. It gives UK enterprises a structured pathway to move from conceptual quantum interest to hands-on experimentation on real quantum hardware. The programme is now in its third cohort.

**Which companies joined QTAP Cohort 3?**
Named participants include NatWest, CTA Fintech Solutions, the Rail Safety and Standards Board (RSSB), and Health Innovation North West Coast. The cohort totals 11 organisations spanning finance, healthcare, defence, logistics, and transport — though not all organisations were individually named in the announcement.

**What quantum hardware does QTAP Cohort 3 use?**
The cohort uses ORCA Computing's PT-2 quantum computer, which is physically deployed at the National Quantum Computing Centre (NQCC). ORCA's PT-2 is a photonic quantum computing system.

**What quantum use cases is NatWest exploring through QTAP?**
NatWest is exploring how quantum solutions could help detect fraud and illicit activity across large transaction networks — a graph-based computational challenge relevant to quantum-enhanced pattern discovery techniques.

**When will QTAP Cohort 3 results be available?**
The programme is scheduled to run until February 2027, at which point cohort results and validated use cases are expected to be reported.

**How does QTAP fit into the UK's broader quantum strategy?**
The programme is designed to support the UK's sovereign quantum capability by building industrial evidence for real-world quantum use cases. It aligns with the UK's Modern Industrial Strategy and the government's investment in the NQCC as a national quantum infrastructure asset.